MedTrace Logo

Pharmacist Management of Paxlovid eVisits

NCT06076863 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2478

Last updated 2024-03-04

No results posted yet for this study

Summary

The goal of this cluster randomized trial is to compare two modes of management -- pharmacist care vs. pooled adult and family medicine physician care -- for electronically submitted requests (e-visits) for Paxlovid by adults with COVID-19. It will compare quality of care based on counseling for common potential drug-drug interactions and time to prescription, as well as the time and financial costs of care in the two groups.

Conditions

Interventions

OTHER

Pharmacist Care

Management of Paxlovid e-visits per regional protocol

OTHER

AFM Pool Care

Management of Paxlovid e-visits per regional and local protocols

Sponsors & Collaborators

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Tracy Lieu, MD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-10-09
Primary Completion
2023-12-11
Completion
2024-01-11

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06076863 on ClinicalTrials.gov